Download Docs
Export

CEBEDEX

85959221 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed June 13, 2013
Serial No. 85959221
Examining Attorney APRIL ELIZABET REEVES
Interlocutory Attorney JENNIFER KRISP
Class Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, bladder disfunction, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse; herb teas for medicinal purposes; 006; 018; 044; 046; 051; 052
CEBEDEX
Status Abandoned after an inter partes decision by the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Trademark Trial and Appeal Board web page.
Opposition 91219254
G. D. Searle & Co. v. GW Pharma Limited
  • GW Pharma Limited;
  • G. D. Searle & Co.;
Opposition 85959221
G. D. Searle & Co. v. GW Pharma Limited
  • GW Pharma Limited;
  • G. D. Searle & Co.;
Last Updated: 3 years, 6 months ago
Filing Date # Docket Text